AZD-9291 mesylate

• CAT Number: I001623
• CAS Number: 1421373-66-1
• Molecular Formula: C₂₉H₃₇N₇O₅S
• Molecular Weight: 595.71
• Purity: ≥95%
• Target: EGFR
• Solubility: 10 mM in DMSO
• Storage: Store at -20°C
• Related CAS: 1421373-65-0(free base)
• IC50: 12.92 nM(Exon 19 deletion EGFR); 11.44 nM(L858R/T790M EGFR)
• InChI: InChI=1S/C28H33N7O2.CH4O3S/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24;1-5(2,3)4/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32);1H3,(H,2,3,4)
• InChIKey: FUKSNUHSJBTCFJ-UHFFFAOYSA-N
• SMILES: CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC.CS(=O)(=O)O

AZD-9291 mesylate (CAT: I001623) is a potent and selective inhibitor of mutated forms of the epidermal growth factor receptor (EGFR). Specifically, it targets EGFR mutations such as T790M, which is associated with resistance to traditional EGFR inhibitors. AZD-9291 mesylate acts by irreversibly binding to the mutant EGFR, inhibiting its tyrosine kinase activity and preventing downstream signaling pathways involved in tumor growth and survival. This targeted therapy has shown promising results in the treatment of non-small cell lung cancer (NSCLC) harboring EGFR mutations, offering a potential treatment option for patients with resistance to standard EGFR inhibitors.

Reference

1: Stinchcombe TE. AZD9291 in epidermal growth factor receptor
inhibitor-resistant non-small-cell lung cancer. Transl Lung Cancer Res. 2016
Feb;5(1):92-4. doi: 10.3978/j.issn.2218-6751.2015.07.19. PubMed PMID: 26958499;
PubMed Central PMCID: PMC4758967.
2: Gautschi O, Aebi S, Heukamp LC. Successful AZD9291 Therapy Based on
Circulating T790M. J Thorac Oncol. 2015 Dec;10(12):e122-3. doi:
10.1097/JTO.0000000000000676. PubMed PMID: 26709490.
3: Remon J, Planchard D. AZD9291 in EGFR-mutant advanced non-small-cell lung
cancer patients. Future Oncol. 2015 Nov;11(22):3069-81. doi: 10.2217/fon.15.250.
Epub 2015 Oct 9. Review. PubMed PMID: 26450446.
4: Jänne PA, Yang JC, Kim DW, Planchard D, Ohe Y, Ramalingam SS, Ahn MJ, Kim SW,
Su WC, Horn L, Haggstrom D, Felip E, Kim JH, Frewer P, Cantarini M, Brown KH,
Dickinson PA, Ghiorghiu S, Ranson M. AZD9291 in EGFR inhibitor-resistant
non-small-cell lung cancer. N Engl J Med. 2015 Apr 30;372(18):1689-99. doi:
10.1056/NEJMoa1411817. PubMed PMID: 25923549.